|
Index of reports
> Cases resulting in hospitalization (131)
> Cases with Asthenia (13)
Below is the selection of adverse event reports related to Levaquin (Levofloxacin) that includes cases resulting in hospitalization where reactions include asthenia.
Adverse event in 60 year old male receiving Levaquin (Levofloxacin)
Reported by a individual with unspecified qualification from United States on 2007-10-23
Patient: 60 year old male, weighing 133.8 kg (294.4 pounds)
Adverse reactions / side effects: Arthralgia, Ocular Hyperaemia, Oedema Peripheral, Rash, Asthenia, DRY Eye, Diabetes Mellitus Inadequate Control
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
Adverse event in 58 year old female receiving Levaquin (Levofloxacin)
Reported by a physician from United States on 2007-10-18
Patient: 58 year old female, weighing 144.2 kg (317.3 pounds)
Adverse reactions / side effects: Weight Decreased, Drug Ineffective, Hypoglycaemia, Hepatic Failure, Headache, Hyperhidrosis, Cardiac Disorder, Herpes Zoster, Weight Increased, Blood Uric Acid Decreased, Kidney Infection, Transient Ischaemic Attack, Diabetes Mellitus Inadequate Control, Cardiac Failure Congestive, Renal Haemorrhage, Cellulitis, Nausea, Rash, Tremor, Renal Failure, Arthralgia, Diabetic Neuropathy, Swelling, Asthenia, Angiopathy, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2006-01-01
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2001-01-01
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2002-01-01
Actos
Dosage: see image
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-01-01
Actos
Byetta
Dosage: 5 mcg, 2 in 1 d, subcutaneous
Indication: Type 2 Diabetes Mellitus
Start date: 2007-07-01
Byetta
Dosage: 5 mcg, 2 in 1 d, subcutaneous
Indication: Weight Decreased
Start date: 2007-07-01
Glipizide
Dosage: 5 mg, 3 in 1 d, per oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2004-01-01
Glyburide
Dosage: 5 mg, 3 in 1 d, per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2001-01-01
Levaquin
Dosage: 750 mg, 1 in 1 d, intravenous
Indication: Kidney Infection
Start date: 2007-01-01
End date: 2007-01-01
Lyrica
Dosage: per oral
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2004-01-01
End date: 2004-01-01
Other drugs received by patient: Ibuprofen; Atacand (Candesartan Cilexetil) (16 Milligram); Lasix (Furosemide) (20 Milligram); Demadex; Nitrostat
Adverse event in 48 year old female receiving Levaquin (Levofloxacin)
Reported by a individual with unspecified qualification from United States on 2007-07-30
Patient: 48 year old female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Confusional State, Glossodynia, Depersonalisation, Nausea, Headache, Paraesthesia, Herpes Zoster, Myalgia, Tendon Pain, Vertigo, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
Adverse event in male receiving Levaquin (Levofloxacin)
Reported by a consumer/non-health professional from United States on 2007-07-16
Patient: male
Adverse reactions / side effects: Weight Decreased, Dysphagia, Renal Failure, Asthenia, Eating Disorder
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
Adverse event in male receiving Levaquin (Levofloxacin)
Reported by a consumer/non-health professional from United States on 2007-07-11
Patient: male
Adverse reactions / side effects: Weight Decreased, Dysphagia, Renal Failure, Asthenia, Eating Disorder
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cipro
Indication: Infection
Levaquin
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Levaquin (Levofloxacin)
Reported by a physician from United States on 2007-07-11
Patient: female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Myalgia, Fatigue, Dyspnoea, Asthenia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin
Administration route: Oral
Indication: Bronchospasm
Levaquin
Administration route: Oral
Indication: Bronchitis
Levaquin
Administration route: Oral
Indication: Sinusitis
Other drugs received by patient: Metformin HCL; Lovastatin; Naproxen
Adverse event in male receiving Levaquin (Levofloxacin)
Reported by a consumer/non-health professional from United States on 2007-07-05
Patient: male
Adverse reactions / side effects: Weight Decreased, Dysphagia, Renal Failure, Asthenia, Eating Disorder
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cipro
Indication: Infection
Levaquin
Indication: Drug USE FOR Unknown Indication
Adverse event in male receiving Levaquin (Levofloxacin)
Reported by a consumer/non-health professional from United States on 2007-07-03
Patient: male, weighing 84.8 kg (186.6 pounds)
Adverse reactions / side effects: Weight Decreased, Pain in Extremity, Impaired Work Ability, Groin Pain, Myalgia, Activities of Daily Living Impaired, Arthralgia, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
Adverse event in female receiving Levaquin (Levofloxacin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-02
Patient: female, weighing 56.2 kg (123.8 pounds)
Adverse reactions / side effects: Restlessness, Hypoaesthesia, Muscle Tightness, Paraesthesia, Anxiety, Joint Range of Motion Decreased, Asthenia, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin
Administration route: Oral
Indication: Bronchitis
Levaquin
Administration route: Oral
Indication: Pneumonia
Other drugs received by patient: Premarin; Xanax
Adverse event in female receiving Levaquin (Levofloxacin)
Reported by a physician from United States on 2007-05-30
Patient: female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Dyspnoea, Asthenia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin
Administration route: Oral
Indication: Bronchospasm
Levaquin
Administration route: Oral
Indication: Bronchitis
Levaquin
Administration route: Oral
Indication: Sinusitis
Other drugs received by patient: Metformin HCL; Lovastatin; Naproxen
Adverse event in 71 year old female receiving Levaquin (Levofloxacin)
Reported by a consumer/non-health professional from United States on 2007-05-02
Patient: 71 year old female
Adverse reactions / side effects: Dyspnoea, Asthenia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
Other drugs received by patient: Metformin HCL; Lovastatin; Naproxen
Adverse event in 71 year old female receiving Levaquin (Levofloxacin)
Reported by a consumer/non-health professional from United States on 2007-04-30
Patient: 71 year old female
Adverse reactions / side effects: Dyspnoea, Asthenia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
Other drugs received by patient: Metformin HCL; Lovastatin; Naproxen
Adverse event in 42 year old male receiving Levaquin (Levofloxacin)
Reported by a individual with unspecified qualification from United States on 2007-02-14
Patient: 42 year old male, weighing 77.1 kg (169.6 pounds)
Adverse reactions / side effects: Oral Intake Reduced, Pain, Photopsia, Hyperhidrosis, Lung Disorder, Hot Flush, Arthralgia, Insomnia, Asthenia, Lethargy, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
Levaquin (Levofloxacin)
|
